相关实验视频

Updated: May 2, 2026

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

无线电频率切除症状,非功能性甲状腺结节:单中心回顾性观察性研究

Huiyin Zhu¹, Lifen Bai¹, Ming Zhou¹

¹Department of Thyroid and Breast Surgery, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Annals of surgical treatment and research

|September 26, 2025

概括

射频除 (RFA) 有效地治疗甲状腺结节 (TNs),显示显著的体积减少和高安全性. 在12个月的时间里,治疗后的结节大小大幅下降.

科学领域:

内分泌学在内分泌学.
最少侵入性的手术

背景情况:

甲状腺结节 (TNs) 是常见的,虽然往往是良性的,但它们会引起需要治疗的症状.
射频除 (RFA) 为TNS提供了一种最少的侵入性治疗选择.

研究的目的:

评估射频除 (RFA) 用于治疗甲状腺结节 (TNs) 的疗效和安全性.

主要方法:

在2020年1月至2023年12月期间,对TN接受RFA的患者进行回顾性分析.
收集了手术前和手术后的数据,包括甲状腺激素水平.
通过测量体积减小 (VR) 和体积减小率 (VRR) 在手术后1,3,6和12个月评估RFA疗效.

主要成果:

在RFA后12个月,与之前的时间点相比,体积减小 (VR) 和体积减小率 (VRR) 显著增加 (P < 0.001).
RFA在改变结节组成方面表现出有效性,并导致术后并发症的发生率较低.

结论:

射频切除 (RFA) 是一种安全有效的治疗甲状腺结节的方法.
该研究证实,在RFA治疗后,TNs的体积显著且逐渐减少.

关键词:

良性结节是一种良性的结节.无线电频率剥离法无线电频率剥离法追溯研究是一项回顾性研究.甲状腺结节甲状腺结节超声波学超声波学超声波学

更多相关视频

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

相关概念视频

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...